LYRM4 Gene Combined oxidative phosphorylation deficiency type 19 Genetic Test sale cost 4400 AED
MT-RNR2 Gene Chloramphenicol resistance MT-RNR2 related Genetic Test sale cost 3200 AED MT-RNR2 Gene Chloramphenicol resistance MT-RNR2 related Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.3,200 د.إCurrent price is: 3,200 د.إ.
MRPL3 Gene Combined oxidative phosphorylation deficiency type 9 Genetic Test sale cost 3200 AED MRPL3 Gene Combined oxidative phosphorylation deficiency type 9 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.3,200 د.إCurrent price is: 3,200 د.إ.
Sale!

LYRM4 Gene Combined oxidative phosphorylation deficiency type 19 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The LYRM4 gene plays a crucial role in the proper functioning of the mitochondrial respiratory chain, which is essential for energy production within cells. Mutations in this gene can lead to Combined Oxidative Phosphorylation Deficiency Type 19 (COXPD19), a rare genetic disorder that affects multiple body systems, leading to a wide range of health issues including developmental delay, muscle weakness, and metabolic abnormalities.

To diagnose this condition, a genetic test specifically targeting the LYRM4 gene is available. This test can confirm the presence of mutations in the LYRM4 gene, providing crucial information for diagnosis, treatment planning, and genetic counseling. The test involves analyzing the patient’s DNA, typically extracted from a blood sample, to identify any genetic alterations in the LYRM4 gene that are known to cause COXPD19.

In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost for the LYRM4 gene test is 4400 AED. DNA Labs UAE is equipped with advanced genetic testing technologies and staffed by experts in the field, ensuring accurate and reliable results. This test is a valuable tool for families seeking answers to complex health issues related to COXPD19, enabling them to make informed decisions about their health care and management of the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

LYRM4 Gene Combined oxidative phosphorylation deficiency type 19 Genetic Test

Test Name: LYRM4 Gene Combined oxidative phosphorylation deficiency type 19 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for LYRM4 Gene Combined oxidative phosphorylation deficiency type 19 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Combined oxidative phosphorylation deficiency type 19.

Test Details

The LYRM4 gene is a gene that is involved in the production of a protein called LYRM4. This protein is important for the function of mitochondria, which are the energy-producing structures within cells.

Combined oxidative phosphorylation deficiency type 19 (COXPD19) is a rare genetic disorder that is caused by mutations in the LYRM4 gene. This condition leads to a deficiency in the oxidative phosphorylation process, which is the main way that cells generate energy.

NGS stands for next-generation sequencing, which is a high-throughput method used to analyze multiple genes simultaneously. A genetic test using NGS technology can be performed to detect mutations in the LYRM4 gene and diagnose COXPD19.

This type of genetic test involves obtaining a DNA sample, typically through a blood or saliva sample, and then sequencing the DNA to identify any mutations or changes in the LYRM4 gene.

The results of the test can help confirm a diagnosis of COXPD19 and provide information about the specific genetic mutation involved. Genetic testing for COXPD19 can be helpful for individuals who have symptoms of the condition, as well as for their family members who may be at risk of inheriting the mutation.

It can also be used for carrier testing in individuals who are planning to have children and want to know if they carry a mutation in the LYRM4 gene.

It’s important to note that genetic testing for COXPD19 should be done under the guidance of a healthcare professional, such as a genetic counselor or geneticist, who can help interpret the results and provide appropriate recommendations and support.

Test Name LYRM4 Gene Combined oxidative phosphorylation deficiency type 19 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for LYRM4 Gene Combined oxidative phosphorylation deficiency type 19 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Combined oxidative phosphorylation deficiency type 19
Test Details

The LYRM4 gene is a gene that is involved in the production of a protein called LYRM4. This protein is important for the function of mitochondria, which are the energy-producing structures within cells.

Combined oxidative phosphorylation deficiency type 19 (COXPD19) is a rare genetic disorder that is caused by mutations in the LYRM4 gene. This condition leads to a deficiency in the oxidative phosphorylation process, which is the main way that cells generate energy.

NGS stands for next-generation sequencing, which is a high-throughput method used to analyze multiple genes simultaneously. A genetic test using NGS technology can be performed to detect mutations in the LYRM4 gene and diagnose COXPD19.

This type of genetic test involves obtaining a DNA sample, typically through a blood or saliva sample, and then sequencing the DNA to identify any mutations or changes in the LYRM4 gene. The results of the test can help confirm a diagnosis of COXPD19 and provide information about the specific genetic mutation involved.

Genetic testing for COXPD19 can be helpful for individuals who have symptoms of the condition, as well as for their family members who may be at risk of inheriting the mutation. It can also be used for carrier testing in individuals who are planning to have children and want to know if they carry a mutation in the LYRM4 gene.

It’s important to note that genetic testing for COXPD19 should be done under the guidance of a healthcare professional, such as a genetic counselor or geneticist, who can help interpret the results and provide appropriate recommendations and support.

SKU: TEST-2243